Increasing urban green spaces in Italy could prevent 28,433 deaths annually, highlighting their critical role in reducing mortality and improving public health.
Vertex doesn’t need to do more testing for rogue gene edits from sickle cell therapy trial, FDA advisors say
Just over a month before the FDA makes a landmark decision about the first-ever therapy to use CRISPR/Cas9 gene editing, the agency is paying close
November 2, 2023